To date, there is scarce evidence regarding the impact of multiple insulin BRs on T1D patients’ glycemic control, especially if the latest recommended metrics, namely time in range (TIR), time above range (TAR), time below range (TBR), and glycemic variability, are considered. The gene discussed is INS; the disease is type 1 diabetes mellitus.